Click Here to return To Results

 

Randomized, Double-Blind, Dose-Comparison Study of Glatiramer Acetate in Relapsing-Remitting MS Neurol 68:939-944, Cohen,J.A.,et a, 2007 See this aricle in Pubmed Article Abstract Glatiramer acetate (GA) 40 mg was safe and well tolerated. The overall efficacy results suggested that a 40-mg dose of GA may be more effective than the currently approved 20-mg daily dose in reducing MRI activity and clinical relapses.

Related Tags

(click to filter results - removes previous filter) cop 1 efficacy MRI MRI,abnormal multiple sclerosis multiple sclerosis,relapsing multiple sclerosis,treatment of safety treatment of neurologic disorder

Click Here to return To Results